Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2026-01-31 @ 5:45 AM
Study NCT ID:
NCT03709550
Status:
WITHDRAWN
Last Update Posted:
2022-10-05
First Post:
2018-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-12
First Submit QC Date:
None
Study First Post Date:
2018-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-03
Last Update Post Date:
2022-10-05
Last Update Post Date Type:
ACTUAL